Mitsui & Co. ("Mitsui") on November 21, 2018, acquired a stake in GOQii Inc. ("GOQii"), a business providing a preve...
As the world's third largest economy, Japan is leading the way for aging societies. Therefore, the Government ...
Eisai Co., Ltd. announced that the latest data on its antiepileptic drug (AED) perampanel (product name: Fycompa) will b...
Takeda has announced that it has received clearance from the European Commission for the proposed acquisition of Shire a...
Alvotech and Fuji Pharma has announced that the two companies are entering into an exclusive partnership for the commerc...
In a multi-year agreement for up to USD 600 million, Mundipharma has acquired the exclusive rights for Invossa in Japan ...
The Inamori Foundation has announced that it has presented its 34th annual Kyoto Prize in Advanced Technology to Dr. Kar...
HeartFlow, Inc. has announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the recommenda...
Singapore – Aiming to close its deal for Shire on Jan. 8, Japanese drugmaker, Takeda Pharmaceutical will ...
Royal Philips, a global leader in health technology, has announced a collaboration with Japanese healthcare informatics ...
A research team from Kyoto University, Japan has conducted the world’s first transplant of induced pluripotent ste...
MEI Pharma, Inc. and Kyowa Hakko Kirin Co., Ltd. (KHK), have announced the execution of a license agreement granting KHK...
Hong Kong Science and Technology Parks Corporation (HKSTP) announced its fruitful participation in promoting Hong K...
Japanese drugmaker Kissei Pharmaceutical has acquired exclusive rights to develop and commercialize Tavalisse (fostamati...
Chitin nanofiber is a new material made from crab shells. In brief, it can be prepared by making chitin on a nanoscale. ...
Mitsui Chemicals, Inc. and Chitose Group, a group of biotechnology startups have jointly launched the "0 to 1 Project" a...
NEC Corporation and Transgene have announced the signing of a Memorandum of Understanding (MoU) for a strategic collabor...
Daiichi Sankyo Company, Limited announced that it has entered into a clinical trial collaboration agreement with Merck K...
Singapore – Mesoblast announces that Japanese licensee JCR Pharmaceuticals Co. Ltd. plans to seek a new...
Johnson & Johnson has announced that they have agreed with Ci:z Holdings Co., Ltd. a Japanese company focused on the...
Eisai Co., Ltd. and MSD K.K., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A., have announced that the t...
Anaeropharma Science and Chugai Pharmaceutical Co., Ltd. headquartered in Tokyo have concluded a collaborative rese...
A joint research group centered around Professor Hideyuki Okano and Associate Professor Jun Kohyama, Department of Physi...
Daiichi Sankyo Company, recently announced that it has submitted a New Drug Application (NDA) to Japan’s Min...
Eisai Co., Ltd. and Purdue Pharma L.P. announced positive topline results from SUNRISE 2, a long-term Phase 3 efficacy a...
Eisai Co., Ltd. has entered into an agreement with Eurofarma Laboratorios, to grant exclusive development and marketing ...
Hitachi, Ltd. announced that its heavy ion beam therapy system has started treatment at Osaka Heavy Ion Therapy Center a...
Innovus Pharmaceuticals, an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effectiv...
The Global Health Innovative Technology (GHIT) Fund has welcomed Ono Pharmaceutical Co., Ltd. (Ono) to join GHIT as a ne...
A team of scientists from Tohoku University in collaboration with Advantest has developed in vivo skin imaging technolog...
GenAhead and ERS Genomics has announced a non-exclusive license agreement to provide GenAhead with access to ERS Genomic...
US based pharmaceutical company Novan has announced an extended license agreement with Sato Pharmaceutical Co, a Japanes...
Daiichi Sankyo Company, Limited has announced that axicabtagene ciloleucel (formerly KTE-C19) has been granted Orphan Dr...
Orgenesis, a manufacturer, service provider and developer of advanced cell therapies, has announced that it has entered ...
Researchers from Eindhoven University of Technology (The Netherlands) and Keio University (Japan) have developed a pract...
Japanese scientist Tasuku Honjo has been awarded this year’s Nobel Prize in physiology or medicine, for his discov...
Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administ...
The Global Health Innovative Technology (GHIT) Fund, Japan recently announced an investment of approximately 420 million...
Peptidream Inc., a public Kanagawa-based biopharmaceutical company has announced that it has entered into a broad-based ...
Anaeropharma Science Inc. headquartered in Tokyo (hereafter "Anaeropharma") has announced that Anaeropharma and Ast...
Takeda Pharmaceutical Company Limited has announced that the European Medicines Agency’s (EMA) Committee for Medic...
Mylan and Fujifilm Kyowa Kirin Biologics recently announced that the European Commission (EC) has granted mar...
Medtronic has initiated a new clinical study in patients implanted with its Resolute Onyx drug-eluting stent (DES) durin...
NEGTEC, an originator of the Sakura Bloom (SKB) cryptocurrency project, has announced a new donation-based crowdfunding ...
Tokyo based Chugai Pharmaceutical and Nippon Shinyaku have launched Gazyva (obinutuzumab), an anti-CD20 monoclonal antib...
Nissui Pharmaceutical Co., Ltd. is carrying out the trial operation to count colonies cultured in the "simple culture me...
Astellas Pharma and Ironwood Pharmaceuticals, recently announced that approval has been obtained in Japan for the guanyl...
Tokyo-headquartered e-commerce group Rakuten Inc’s CEO and chairman of Rakuten Aspyrian Hiroshi Mikitani has led a...
Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada...
Asia's largest exhibition and conference dedicated to the Medical Device Design and Manufacturing industry, "Medtec...
Shire plc has announced that its partner in Japan, Shionogi & Co., Ltd has submitted a New Drug Application (NDA) fo...
Singapore – Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company focused on the development o...
Eisai Inc. and Merck known as MSD outside of the United States and Canada, announced the U.S. Food and Drug Administrati...
Dublin-based Medtronic has announced the commercial launch of the IN.PACT Admiral Drug-Coated Balloon (DCB) in Japan. I...
Japan based Kaneka Corporation has installed continuous manufacturing equipment to be applied to pharmaceutical products...
Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) has announced that results of the global Phase 3 MAVORIC study (Mogamulizumab...
Researchers at Okayama University developed a supporting device for accurately placing hemodialysis catheters on kidney ...
Takeda has entered into a $100 million partnership with newly-launched biotech Ambys Medicines to support its discovery ...
Qiagen N.V. has announced a collaboration with SRL, Inc., the largest clinical testing laboratory company in Japan, to p...
Eisai Co., Ltd. announced that it has entered into an agreement to grant exclusive development and marketing rights for ...
Eisai Co., Ltd. and Merck & Co., Inc. announced that the U.S. Food and Drug Administration (FDA) granted Break...
A team of researchers from Kyoto University, Japan has announced the world's first human trial using a kind of stem cell...
SanBio, Inc., a scientific leader in regenerative medicine for neurological disorders, has announced that it has been aw...
Mylan N.V. and Fujifilm Kyowa Kirin Biologics Co., Ltd. announced that the European Medicines Agency's Committee for Med...
Japan's Solasia Pharma, a specialty pharmaceutical company based in Asia, has officially announced that Sancuso (Granise...
Eisai Co., Ltd. and Biogen Inc. announced detailed results from a Phase II clinical study (Study 202) of the investigati...
Terumo Corporation recently announced that it has entered into an agreement to acquire Essen Technology (Beijing) Co., L...
Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs currently delivered via...
Researchers at Riken and the National Cancer Centre in Japan have succeeded in using artificial intelligence (AI) to ide...
Sato Pharmaceutical obtained marketing and manufacturing approval for NAILIN® Capsules 100mg as an oral treatment fo...
Eisai Co., Ltd. announces that a total of 13 presentations highlighting results from a Phase II clinical study (Study 20...
Japan's Otsuka Pharmaceutical recently announced that it has acquired US-based Visterra for approximately US...
leon-nanodrugs GmbH is pleased to announce that its proprietary MicroJet Reactor nano-technology has been selected ...
Otsuka Pharmaceutical Co., Ltd. and Visterra, Inc. have announced that they have entered into a definitive merger a...
Japan's Takeda Pharmaceutical Company recently announced that it has obtained a New Drug Application Approval from the J...
A group of researchers at the University of Tokyo, Japan, has developed a method to produce steroid antibiotics that do ...
Royal Philips, a global leader in health technology, and Japan-based Showa University announced the launch of Japan's fi...
Chugai Pharmaceutical Co., Ltd. had exercised its right to terminate without cause the License, Development and Commerci...
Pharma major Lupin and Nichi-Iko announced that the two companies have entered into an agreement for the distribution, p...
US-based Sage Therapeutics, and Japan's Shionogi recently announced they have entered into a strategic collaboratio...
AbbVie has partnered with Eisai and its gastrointestinal diseases unit EA Pharma to introduce an auto-injection delivery...
India’s first tech induced Ayurveda platform, NirogStreet raising USD 300k from the Japanese venture fund Spiral V...
Singapore – VistaGen Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing and commer...
Fluence Analytics, a manufacturer of industrial and laboratory analytics products has announced that it has signed a dis...
Verastem, Inc. and Yakult Honsha Co., Ltd. have announced their entry into an exclusive licensing agreement for Yakult t...
The Global Health Innovative Technology (GHIT) Fund has announced the appointment of Hiroki Nakatani, MD, PhD, MHPEd, fo...
Japan’s Astellas Pharma recently announced that the U.S. Food and Drug Administration (FDA) has accepted, with Pri...
Researchers in the U.S. and Japan plan to use Radio frequency identification (RFID) chips for keeping track of organoids...
Singapore- Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company focused on the development of diagn...
Eisai Inc. and Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that the U.S. Food and Dr...
Eisai Co., Ltd. and Purdue Pharma L.P. announced they will present the latest data from two key Phase I clinical studies...
Global drug giant, AstraZeneca has submitted a supplemental new drug application (sNDA) to Japan’s Pharmaceuticals...
Singapore – Results published in the International Journal of Cardiology show that the 0-hour/1-hou...
Japan's Takeda Pharmaceutical recently announced it has entered into an agreement to sell its majority shareholding...
A special health ministry panel gave Osaka University the approval to carry out a study involving the use of induce...
Platelet BioGenesis, a pioneer in the production of functional human platelets from stem cells, has announced it has lic...
Kaneka Corporation, the Japan based chemical manufacturing company, is set to appeal to the District Court for the Centr...
Aquinox Pharmaceuticals, a clinical-stage pharmaceutical company discovering and developing novel drug candidate...
Singapore– Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($61.50 billion) a...
Japanese drugmaker Ono Pharmaceutical has submitted a new drug application for the approval of pheochromocytoma (PCC) tr...
